CRL vs INR · rev $2.00B vs P/E 23, rev $356.4M
Charles River Laboratories (CRL) versus Infinity Natural Resources, Inc. (INR) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Infinity Natural Resources, Inc. (INR) is a oil & gas e&p company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported INR revenue for 2025-12-31 was $356.4M. Net income was $13.8M. Revenue was up 37.6% from 2024-12-31 to 2025-12-31. INR currently screens at market cap $1.18B and trailing P/E 23.2.
CRL currently screens at market cap $7.78B. INR currently screens at market cap $1.18B and trailing P/E 23.2.
Not investment advice. Open the CRL and INR stock pages for the full models.
Not investment advice.